CHARACTERIZATION OF CHRONIC HEPATITIS PATIENTS BASED ON BPJS KESEHATAN SAMPLE DATA, 2015-2023
DOI:
https://doi.org/10.21460/bikdw.v10i2.1217Keywords:
chronic hepatitis, BPJS Kesehatan, epidemiology, Indonesia, JKNAbstract
Background: Chronic hepatitis remains a significant global health concern, particularly in Southeast Asia. Indonesia faces a growing burden of chronic hepatitis B and C infections, yet large-scale population-based analyses remain limited. This study aims to characterize the demographic and clinical profiles of chronic hepatitis patients in Indonesia using national health insurance data.
Objective: To describe the demographic distribution, healthcare utilization patterns, and associated comorbidities of chronic hepatitis patients based on BPJS Kesehatan sample data from 2015 to 2023.
Methods: A retrospective cohort study design was employed using the BPJS Kesehatan National Health Insurance Sample Database covering the years 2015–2023. Patients with a primary diagnosis of chronic hepatitis were identified. Variables analyzed included demographic factors (age, province of residence, and insurance class), healthcare facility type, and clinical comorbidities. Descriptive statistics were used to summarize the data.
Results: A total of 1,370 chronic hepatitis cases were identified. The highest number of cases occurred in Central Java (15.33%), East Java (12.55%), and West Java (8.39%). Most patients received care in Type C hospitals (584 patients), followed by Type B (347) and Type A (291). Nearly half of the patients (47%) were BPJS Class 3 members, indicating a predominance among lower socioeconomic groups. The most common hepatic complications were liver cirrhosis (12.03%), hepatocellular carcinoma (4.16%), and hepatic failure (1.17%). Non-hepatic comorbidities included functional dyspepsia (3.8%), diabetes mellitus type 2 (3.35%), and hypertension (1.62%).
Conclusion: The analysis highlights that chronic hepatitis in Indonesia predominantly affects individuals in their productive age, with the highest concentration in the Java region and among lower-income populations. These findings underscore the need for strengthened public health interventions, including early screening, vaccination, and equitable access to care, particularly in high-burden regions.
Keywords: Chronic hepatitis, BPJS Kesehatan, epidemiology, liver disease, Indonesia
References
Razavi-Shearer D, Gamkrelidze I, Pan C, et al. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol 2023; 8: 879–907.
World Health Organization. Global Hepatitis Report 2024 : Action for Access in Low- and Middle-Income Countries. World Health Organization, https://www.who.int/publications/i/item/9789240091672 (2024).
H Muljono D. Epidemiology of Hepatitis B and C in Republic of Indonesia. Euroasian J Hepatogastroenterol 2017; 7: 55–59.
Muljono DH, Wijayadi T, Sjahril R. Hepatitis B Virus Infection among Health Care Workers in Indonesia. Euroasian J Hepatogastroenterol 2018; 8: 88–92.
Purnomo HD, Farhanah N, Permatadewi CO, et al. Regional epidemiological study of hepatitis B, hepatitis C, and human immunodeficiency virus among prisoners. BMC Public Health 2025; 26: 129.
Trickey A, Hiebert L, Perfect C, et al. Hepatitis C virus elimination in Indonesia: Epidemiological, cost and cost?effectiveness modelling to advance advocacy and strategic planning. Liver International 2020; 40: 286–297.
Sugiharto VD, Hafza N, Muhammadiy NS, et al. Prevalence of occult hepatitis B infection and hepatitis B genotype characterization among blood donors in Jember Regency, East Java, Indonesia. BMC Infect Dis 2025; 25: 1462.
Dwiartama A, Nirbayati WF, Giri-Rachman EA, et al. Knowledge, Attitude, and Practice towards Hepatitis B Infection Prevention and Screening among Indonesians. Int J Environ Res Public Health 2022; 19: 4644.
Machmud PB, Führer A, Gottschick C, et al. Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study. Vaccines (Basel) 2023; 11: 398.
Imai K, Takai K, Hanai T, et al. Sustained virological response by direct acting antivirals reduces the recurrence risk of hepatitis C related hepatocellular carcinoma after curative treatment. Mol Clin Oncol. Epub ahead of print 29 November 2019. DOI: 10.3892/mco.2019.1956.
Muneera K, Muhammad T, Althaf S. Socio-demographic and lifestyle factors associated with intrinsic capacity among older adults: evidence from India. BMC Geriatr 2022; 22: 851.
Wong JJ, Côté P, Tricco AC, et al. Assessing the validity of health administrative data compared to population health survey data for the measurement of low back pain. Pain 2021; 162: 219–226.
Kurniawan J, Aprilicia G, Purnomo HD, et al. Factors Associated with Hepatitis B and Hepatitis C among Infected Patients in Indonesia and Their Knowledge and Attitude: A Multicenter Observational Study. Acta Med Indones; 56, https://actamedindones.org/index.php/ijim/article/view/2448 (2024).
Brown R, Goulder P, Matthews PC. Sexual Dimorphism in Chronic Hepatitis B Virus (HBV) Infection: Evidence to Inform Elimination Efforts. Wellcome Open Res 2022; 7: 32.
Gao L, Ren Y, Hu S, et al. Global, regional, and national total burden related to hepatitis B and attributable risk factors in adults aged 65?years and older from 1990 to 2021 and projection to 2030. Front Public Health; 13. Epub ahead of print 25 September 2025. DOI: 10.3389/fpubh.2025.1654356.
Adeyemi OA, Mitchell A, Shutt A, et al. Hepatitis B virus infection among men who have sex with men and transgender women living with or at risk for HIV: a cross sectional study in Abuja and Lagos, Nigeria. BMC Infect Dis 2021; 21: 654.
Downloads
Published
Issue
Section
Citation Check
License
Copyright (c) 2025 Andhika Putra Rahardjo
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish in Berkala Ilmiah Kedokteran Duta Wacana agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This work is licensed under CC BY-SA 4.0
